19.11.2025, Ennigerloh/Frankfurt. Rottendorf Pharma has been honored with the CDMO Leadership Award Europe 2025. The American online platform Outsourced Pharma presented the CDMO Leadership Award for Europe for the first time. The decisive factor was customer surveys in which clients evaluated their service providers for the development and manufacturing of pharmaceutical products. The announcement of the winners and the award ceremony took place at the end of October in Frankfurt.

Erich Scheibner, Managing Director at Rottendorf Pharma, accepted the award: “I am particularly pleased that our customers appreciate our collaboration and have evaluated us accordingly. The award is both an honor and an incentive for us to meet our customers’ needs in the best possible way every day and to be a reliable partner. This applies to the entire team at Rottendorf Pharma, which has earned this award.”

In March 2025, Rottendorf Pharma had already been honored in the United States with the CDMO Leadership Award 2025 in the category Small Molecule Dosage Form, International. In this category, Rottendorf Pharma has now also been recognized across Europe. 

Louis Garguilo, Chief Editor, Outsourced Pharma: “Outsourced Pharma is proud to host our CDMO Leadership Awards in Europe for the first time in our history of over a decade. The 2025 CDMO Leadership Awards Europe is a well-deserved recognition to European organizations that have demonstrated excellence in contract development and manufacturing. These awards are the most important in our industry because they are based on the judgement of biopharma sponsors and the value they place in trusted partnerships.”